CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the recipient of a large increase in short interest in the month of July. As of July 15th, there was short interest totaling 3,862 shares, an increase of 1,765.7% from the June 30th total of 207 shares. Based on an average daily volume of 1,644 shares, the short-interest ratio is presently 2.3 days.
CSPC Pharmaceutical Group Stock Performance
Shares of CSPCY opened at C$4.31 on Friday. CSPC Pharmaceutical Group has a one year low of C$3.26 and a one year high of C$5.83. The company has a 50-day simple moving average of C$3.78 and a two-hundred day simple moving average of C$4.40.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.
The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.
Featured Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.
